PI3-kinase p85alpha is a target molecule of proline-rich antimicrobial peptide to suppress proliferation of ras-transformed cells - PubMed (original) (raw)

PI3-kinase p85alpha is a target molecule of proline-rich antimicrobial peptide to suppress proliferation of ras-transformed cells

K Tanaka et al. Jpn J Cancer Res. 2001 Sep.

Abstract

PR-39, which is an endogenous antimicrobial peptide, can bind to Src homology 3 domains of the NADPH complex protein p47(phox) and the signaling adapter protein p130(Cas). Recently, we have reported that PR-39 gene transduction altered invasive activity and actin structure of human hepatocellular carcinoma cells, suggesting that this peptide affects cellular signaling due to its proline-rich motif. In order to clarify the mechanism of the PR-39 functions, we transfected the PR-39 gene into mouse NIH3T3 cells which had already been transformed with human activated k-ras gene. The PR-39 gene transfectant showed a reorganization of actin structure and suppression of cell proliferation both in vitro and in vivo. Decreases of MAP (mitogen-activated protein) kinase activity, cyclin D1 expression and JNK activity were observed in the PR-39 gene transfectant. Co-immunoprecipitation analysis revealed that PR-39 binds to PI3-kinase p85alpha, which is a regulatory subunit of PI3-kinase and one of the effectors by which ras induces cytoskeletal changes and stimulates mitogenesis. The PI3-kinase activity of the PR-39 gene transfectant was decreased compared with that of the ras transformant. These results suggest that PR-39 alters actin structure and cell proliferation rate by binding to PI3-kinase p85alpha and suppressing the PI3-kinase activity.

PubMed Disclaimer

Similar articles

• The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-kinase-Akt signaling for fibroblast transformation.
  Tognon C, Garnett M, Kenward E, Kay R, Morrison K, Sorensen PH. Tognon C, et al. Cancer Res. 2001 Dec 15;61(24):8909-16. Cancer Res. 2001. PMID: 11751416
• Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
  Rusyn EV, Reynolds ER, Shao H, Grana TM, Chan TO, Andres DA, Cox AD. Rusyn EV, et al. Oncogene. 2000 Sep 28;19(41):4685-94. doi: 10.1038/sj.onc.1203836. Oncogene. 2000. PMID: 11032018
• R-Ras3, a brain-specific Ras-related protein, activates Akt and promotes cell survival in PC12 cells.
  Kimmelman AC, Osada M, Chan AM. Kimmelman AC, et al. Oncogene. 2000 Apr 13;19(16):2014-22. doi: 10.1038/sj.onc.1203530. Oncogene. 2000. PMID: 10803462
• Differential contribution of the ERK and JNK mitogen-activated protein kinase cascades to Ras transformation of HT1080 fibrosarcoma and DLD-1 colon carcinoma cells.
  Plattner R, Gupta S, Khosravi-Far R, Sato KY, Perucho M, Der CJ, Stanbridge EJ. Plattner R, et al. Oncogene. 1999 Mar 11;18(10):1807-17. doi: 10.1038/sj.onc.1202482. Oncogene. 1999. PMID: 10086335
• Implication of atypical protein kinase C isozymes lambda and zeta in Ras mediated reorganization of the actin cytoskeleton and cyclin D1-induction.
  Hellbert K, Kampfer S, Maly K, Hochholdinger F, Mwanjewe J, Baier G, Uberall F, Grunicke HH. Hellbert K, et al. Adv Enzyme Regul. 2000;40:49-62. doi: 10.1016/s0065-2571(99)00038-2. Adv Enzyme Regul. 2000. PMID: 10828345 Review. No abstract available.

Cited by

• Anti-Cancer Peptides: Status and Future Prospects.
  Ghaly G, Tallima H, Dabbish E, Badr ElDin N, Abd El-Rahman MK, Ibrahim MAA, Shoeib T. Ghaly G, et al. Molecules. 2023 Jan 23;28(3):1148. doi: 10.3390/molecules28031148. Molecules. 2023. PMID: 36770815 Free PMC article. Review.
• Direct association of heat shock protein 20 (HSPB6) with phosphoinositide 3-kinase (PI3K) in human hepatocellular carcinoma: regulation of the PI3K activity.
  Matsushima-Nishiwaki R, Kumada T, Nagasawa T, Suzuki M, Yasuda E, Okuda S, Maeda A, Kaneoka Y, Toyoda H, Kozawa O. Matsushima-Nishiwaki R, et al. PLoS One. 2013 Nov 6;8(11):e78440. doi: 10.1371/journal.pone.0078440. eCollection 2013. PLoS One. 2013. PMID: 24223153 Free PMC article.
• Antimicrobial Peptides from Fruits and Their Potential Use as Biotechnological Tools-A Review and Outlook.
  Meneguetti BT, Machado LD, Oshiro KG, Nogueira ML, Carvalho CM, Franco OL. Meneguetti BT, et al. Front Microbiol. 2017 Jan 10;7:2136. doi: 10.3389/fmicb.2016.02136. eCollection 2016. Front Microbiol. 2017. PMID: 28119671 Free PMC article. Review.
• Membrane-active host defense peptides--challenges and perspectives for the development of novel anticancer drugs.
  Riedl S, Zweytick D, Lohner K. Riedl S, et al. Chem Phys Lipids. 2011 Nov;164(8):766-81. doi: 10.1016/j.chemphyslip.2011.09.004. Epub 2011 Sep 16. Chem Phys Lipids. 2011. PMID: 21945565 Free PMC article. Review.
• NADPH oxidases: Current aspects and tools.
  Schröder K. Schröder K. Redox Biol. 2020 Jul;34:101512. doi: 10.1016/j.redox.2020.101512. Epub 2020 May 23. Redox Biol. 2020. PMID: 32480354 Free PMC article. Review.

References

1. 1. Agerberth , B. , Lee , J.‐Y. , Bergman , T. , Carlruist , M. , Boman , H. G. , Mutt , V. and Jornvall , H . Amino acid sequence of PR‐39: isolation from pig intestine of a new member of the family of proline‐arginine‐rich antibacterial peptides . Eur. J. Biochem. , 202 , 849 – 854 ( 1991. ). - PubMed
2. 1. Storici , P. and Zanetti , M.A cDNA derived from pig bone marrow cells predicts a sequence identical to the intestinal antibacterial peptide PR‐39 . Biochem. Biophys. Res. Commun. , 196 , 1058 – 1065 ( 1993. ). - PubMed
3. 1. Boman , H. G . Peptide antibiotics and their role in innate immunity . Annu. Rev. ImmunoL , 13 , 61 – 92 ( 1995. ). - PubMed
4. 1. Gallo , R. L. , Ono , M. , Povsic , T. , Page , C. , Eriksson , E. , Klagsbrunl , M. and Bernfield , M.Syndecan, cell surface heparan sulfate proteoglycans, are induced by a proline‐rich antimicrobial peptide from wounds . Proc. Natl. Acad. Sci. USA , 91 , 11035 – 11039 ( 1994. ). - PMC - PubMed
5. 1. Li , J. , Post , M. , Vokk , R. , Gao , Y. , Li , M. , Metais , C. , Sato , K. , Tsai , J. , Aird , W. , Rosenberg , R. D. , Hanpton , T. G. , Ki , J. , Sellke , F. , Carmeriet , P. and Simons , M.PR‐39, a peptide regulator of angiogenesis . Nat. Med. , 1 , 49 – 55 ( 2000. ). - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal